Advertisement

Reactions Weekly

, Volume 1635, Issue 1, pp 103–103 | Cite as

Dabrafenib/trametinib

Transaminase elevation and pyrexia following off label use: case report
Case report

Reference

  1. Marquez-Rodas I, et al. Exclusion criteria vs reality: Dual BRAF/MEK inhibition and radiotherapy in a patient with melanoma metastatic to the brain and ECOG 3. Tumori 102 (Suppl. 2): S54-S56, Nov 2016. Available from: URL: http://doi.org/10.5301/tj.5000408 - SpainCrossRefGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2017

Personalised recommendations